Alterity Therapeutics (ATHE) Short Interest Ratio & Short Volume $2.20 +0.10 (+4.76%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends Alterity Therapeutics Short Interest DataAlterity Therapeutics (ATHE) has a short interest of 2,000 shares, representing 0.02% of the float (the number of shares available for trading by the public). This marks a -45.95% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 50,094 shares to cover all short positions.Current Short Interest2,000 sharesPrevious Short Interest3,700 sharesChange Vs. Previous Month-45.95%Dollar Volume Sold Short$2,820.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares7,305,000 sharesFloat Size8,450,000 sharesShort Percent of Float0.02%Today's Trading Volume26,532 sharesAverage Trading Volume50,094 sharesToday's Volume Vs. Average53% Short Selling Alterity Therapeutics? Sign up to receive the latest short interest report for Alterity Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATHE Short Interest Over TimeATHE Days to Cover Over TimeATHE Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Alterity Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20242,000 shares $2,820.00 -46.0%0.0%0 $1.41 11/15/20243,700 shares $4,088.50 +2.8%0.0%0.3 $1.11 10/31/20243,600 shares $4,140.00 -41.9%0.0%0.3 $1.15 10/15/20246,200 shares $7,810.14 -36.1%0.1%0.4 $1.26 9/30/20249,700 shares $12,731.25 -22.4%0.1%0.3 $1.31 9/15/202412,500 shares $15,750.00 -40.5%0.2%0.4 $1.26 Get the Latest News and Ratings for ATHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202421,000 shares $31,290.00 -8.7%0.3%0.6 $1.49 8/15/202423,000 shares $31,740.00 -18.2%0.3%0.7 $1.38 7/31/202428,100 shares $44,957.19 +57.0%0.3%0.8 $1.60 7/15/202417,900 shares $35,979.00 +33.6%0.2%0.4 $2.01 6/30/202413,400 shares $24,254.00 -40.4%0.2%0.2 $1.81 6/15/202422,500 shares $41,850.00 +8.2%0.3%0.3 $1.86 5/31/202420,800 shares $38,896.00 -40.6%0.3%0.3 $1.87 5/15/202435,000 shares $71,400.00 -59.3%0.4%0.4 $2.04 4/30/202485,900 shares $179,960.50 -4.9%1.0%1.1 $2.10 4/15/202490,300 shares $221,235.00 +290.9%1.1%1.1 $2.45 3/31/202423,100 shares $47,817.00 -12.5%0.3%0.6 $2.07 3/15/202426,400 shares $46,464.00 +47.5%0.3%0.6 $1.76 2/29/202417,900 shares $33,473.00 -52.7%0.2%0.3 $1.87 2/15/202437,800 shares $76,356.00 +25.6%0.5%0.1 $2.02 1/31/202430,100 shares $63,511.00 +85.8%N/A0 $2.11 1/15/202416,200 shares $30,780.00 -77.0%0.3%0 $1.90 12/31/202370,500 shares $175,545.00 +22.8%1.2%0.1 $2.49 12/15/202357,400 shares $173,922.00 +12.6%1.3%0.1 $3.03 11/30/202351,000 shares $92,310.00 +684.6%1.2%0.1 $1.81 11/15/20236,500 shares $15,925.00 -11.0%0.2%1.2 $2.45 10/31/20237,300 shares $17,022.14 -32.4%0.2%2.6 $2.33 10/15/202310,800 shares $26,244.00 -12.9%0.3%3.4 $2.43 9/30/202312,400 shares $30,752.00 -13.3%0.3%3.2 $2.48 9/15/202314,300 shares $37,180.00 -14.4%0.4%3.6 $2.60 8/31/202316,700 shares $45,257.00 -13.0%0.4%3.9 $2.71 8/15/202319,200 shares $54,528.00 +12.9%0.5%4 $2.84 7/31/202317,000 shares $49,300.00 +54.6%0.4%3.7 $2.90 7/15/202311,000 shares $31,128.90 +15.8%0.3%2.3 $2.83 6/30/20239,500 shares $26,505.00 -41.7%0.2%2.2 $2.79 6/15/202316,300 shares $47,107.00 +6.5%0.4%2.3 $2.89 5/31/202315,300 shares $44,523.00 +1.3%0.4%0.9 $2.91 5/15/202315,100 shares $43,790.00 +0.7%0.4%0.9 $2.90 4/30/202315,000 shares $41,998.50 -35.3%0.4%0.7 $2.80 4/15/202323,200 shares $66,816.00 -27.3%0.6%1 $2.88Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. 3/31/202331,900 shares $88,682.00 +423.0%0.8%1.1 $2.78 3/15/20236,100 shares $15,921.00 -14.1%0.2%0.2 $2.61 2/28/20237,100 shares $22,791.00 +6.0%0.2%0.4 $3.21 2/15/20236,700 shares $20,167.00 -22.1%0.2%0.4 $3.01 1/31/20238,600 shares $33,626.00 -34.4%0.2%0.5 $3.91 1/15/202313,100 shares $54,365.00 +10.1%0.3%1 $4.15 12/30/202211,900 shares $41,435.80 -90.5%N/A1.1 $3.48 12/15/2022125,500 shares $40,172.55 -3.9%N/A2.2 $0.32 11/30/2022130,600 shares $47,329.44 -15.3%N/A1.5 $0.36 11/15/2022154,100 shares $61,640.00 -33.1%N/A1.6 $0.40 10/31/2022230,200 shares $90,445.58 -6.9%N/A2.3 $0.39 10/15/2022247,200 shares $113,687.28 -2.4%N/A2.3 $0.46 9/30/2022253,200 shares $111,433.32 -4.3%N/A2.3 $0.44 9/15/2022264,700 shares $153,472.80 +22.5%N/A2.3 $0.58 8/31/2022216,100 shares $121,037.61 +27.5%N/A2.5 $0.56 8/15/2022169,500 shares $105,123.90 -34.9%N/A2.3 $0.62 7/31/2022260,300 shares $156,960.90 +0.4%N/A3.5 $0.60 7/15/2022259,300 shares $163,359.00 +9.7%N/A2.8 $0.63 6/30/2022236,400 shares $144,440.40 +36.5%N/A2.8 $0.61 6/15/2022173,200 shares $107,418.64 -30.2%N/A2 $0.62 5/31/2022248,000 shares $166,160.00 -13.9%N/A2.8 $0.67 5/15/2022287,900 shares $190,762.54 -25.4%N/A2.7 $0.66 4/30/2022385,700 shares $284,299.47 +63.5%N/A2.9 $0.74 4/15/2022235,900 shares $184,002.00 -7.6%N/A1.8 $0.78 3/31/2022255,200 shares $211,560.80 +13.8%N/A0.1 $0.83 3/15/2022224,200 shares $159,742.50 -37.9%N/A0.1 $0.71 2/28/2022360,800 shares $306,680.00 -22.9%N/A0.2 $0.85 2/15/2022467,900 shares $427,660.60 -24.4%N/A0.2 $0.91 1/31/2022619,200 shares $582,233.76 -44.7%N/A0.3 $0.94 1/15/20221,120,000 shares $909,216.00 +231.1%N/A0.4 $0.81 12/31/2021338,300 shares $243,576.00 -16.6%N/A0.1 $0.72 12/15/2021405,600 shares $349,627.20 -32.1%N/A1 $0.86 11/30/2021597,000 shares $579,090.00 -2.4%N/A1.3 $0.97 11/15/2021611,900 shares $712,496.36 -25.9%N/A1.3 $1.16 10/29/2021826,100 shares $1.01 million +19.1%N/A1.6 $1.22 10/15/2021693,500 shares $908,485.00 -6.4%N/A0.5 $1.31 9/30/2021740,700 shares $940,689.00 -13.0%N/A0.4 $1.27 9/15/2021851,600 shares $1.10 million +1.1%N/A0.1 $1.29 8/31/2021842,100 shares $1.15 million -11.4%N/A0.1 $1.36 8/13/2021950,600 shares $1.28 million -8.6%N/A0.1 $1.35 7/30/20211,040,000 shares $1.34 million -9.6%N/A0.2 $1.29 7/15/20211,150,000 shares $1.73 million +108.0%N/A0.2 $1.50 6/30/2021552,800 shares $718,640.00 -13.4%N/A0.1 $1.30 6/15/2021638,400 shares $874,608.00 +9.6%N/A0.4 $1.37 5/28/2021582,300 shares $780,282.00 -9.3%N/A0.4 $1.34 5/14/2021642,200 shares $732,108.00 -28.3%N/A0.4 $1.14 4/30/2021895,500 shares $1.33 million +304.1%N/A0.5 $1.49 4/15/2021221,600 shares $292,512.00 +31.0%N/A0.1 $1.32 3/31/2021169,200 shares $240,264.00 +18.0%N/A0.3 $1.42 3/15/2021143,400 shares $246,648.00 +412.1%N/A0.2 $1.72Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. 2/26/202128,000 shares $47,320.00 -71.6%N/A0 $1.69 2/12/202198,700 shares $203,322.00 +961.3%N/A0.1 $2.06 1/29/20219,300 shares $15,717.00 -90.6%N/A0 $1.69 1/15/202199,200 shares $174,592.00 +91.1%N/A0 $1.76 12/31/202051,900 shares $72,660.00 -10.1%N/A0 $1.40 12/15/202057,700 shares $86,550.00 -84.0%N/A0 $1.50 11/30/2020360,800 shares $559,240.00 +574.4%N/A0.2 $1.55 11/15/202053,500 shares $61,525.00 +29.5%N/A0 $1.15 10/30/202041,300 shares $56,994.00 +1,232.3%N/A0.4 $1.38 10/15/20203,100 shares $6,293.00 -40.4%N/A0 $2.03 9/30/20205,200 shares $10,504.00 -82.7%N/A0 $2.02 9/15/202030,000 shares $62,100.00 -86.2%N/A0 $2.07 ATHE Short Interest - Frequently Asked Questions What is Alterity Therapeutics' current short interest? Short interest is the volume of Alterity Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 2,000 shares of ATHE short. 0.02% of Alterity Therapeutics' shares are currently sold short. Learn More on Alterity Therapeutics' current short interest. What is a good short interest percentage for Alterity Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Alterity Therapeutics' floating shares are currently sold short. Is Alterity Therapeutics' short interest increasing or decreasing? Alterity Therapeutics saw a decrease in short interest during the month of November. As of November 30th, there was short interest totaling 2,000 shares, a decrease of 45.9% from the previous total of 3,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alterity Therapeutics' float size? Alterity Therapeutics currently has issued a total of 7,305,000 shares. Some of Alterity Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alterity Therapeutics currently has a public float of 8,450,000 shares. How does Alterity Therapeutics' short interest compare to its competitors? 0.02% of Alterity Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Alterity Therapeutics: SELLAS Life Sciences Group, Inc. (12.86%), Cue Biopharma, Inc. (1.58%), Oncolytics Biotech Inc. (2.97%), BeyondSpring Inc. (8.38%), Atara Biotherapeutics, Inc. (12.95%), Spero Therapeutics, Inc. (0.91%), Connect Biopharma Holdings Limited (0.11%), Mural Oncology plc (3.07%), Invivyd, Inc. (6.60%), Aadi Bioscience, Inc. (1.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Alterity Therapeutics stock? Short selling ATHE is an investing strategy that aims to generate trading profit from Alterity Therapeutics as its price is falling. ATHE shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alterity Therapeutics? A short squeeze for Alterity Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATHE, which in turn drives the price of the stock up even further. How often is Alterity Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATHE, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies SELLAS Life Sciences Group Short Interest Data Cue Biopharma Short Interest Data Oncolytics Biotech Short Interest Data BeyondSpring Short Interest Data Atara Biotherapeutics Short Interest Data Spero Therapeutics Short Interest Data Connect Biopharma Short Interest Data Mural Oncology Short Interest Data Invivyd Short Interest Data Aadi Bioscience Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATHE) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Alterity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATHE Stock Alerts